Cingestol
 | |
| Clinical data | |
|---|---|
| Trade names | Lutisan |
| Other names | 19-Nor-17α-pregn-5-en-20-yn-17β-ol; O.V. 28[1][2] |
| Routes of administration | Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.037.225 |
| Chemical and physical data | |
| Formula | C20H28O |
| Molar mass | 284.443 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cingestol (INN, USAN) (former tentative brand name Lutisan),[3] also known as 17α-ethynylestr-5-en-17β-ol,[4] is a steroidal progestin of the 19-nortestosterone group[5][6] that was never marketed.[7] It was synthesized in 1969[7] and was developed in the 1970s by Organon as a low-dose, progestogen-only contraceptive,[8][9][10][11] but in 1984, was still described as "under investigation".[12] The drug is an isomer of lynestrenol with the double bond between C5 and C6.[1]
See also
[edit]References
[edit]- ^ a b Tausk M (1975). Pharmacology of Hormones. Thieme. p. 126,129. ISBN 978-3-13-518901-7.
- ^ Concours médical. 1976. p. 1083.
- ^ Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. 1987. p. 2995.
- ^ Brotherton J (1976). Sex hormone pharmacology. Academic Press. p. 12. ISBN 978-0-12-137250-7.
- ^ Korolkovas A (16 August 1988). Essentials of Medicinal Chemistry. Wiley. ISBN 978-0-471-88356-2.
- ^ WHO Technical Report Series. World Health Organization. 1981. p. 75. ISBN 9789241206570.
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 279–. ISBN 978-1-4757-2085-3.
- ^ Tapingkae A (1974). Directory of selected scholars and researchers in Southeast Asia. Regional Institute of Higher Education and Development. p. 687.
- ^ Briggs MH, Briggs M (1976). Biochemical contraception: prospects for human development. Academic Press. p. 283. ISBN 978-0-12-134640-9.
- ^ Aref I, Hefnawi F, Kandil O, Aziz MT (August 1973). "Effect of minipills on physiologic responses of human cervical mucus, endometrium, and ovary". Fertility and Sterility. 24 (8): 578–583. doi:10.1016/s0015-0282(16)39850-8. PMID 4124151.
- ^ Kićović PM, Kovacević S, Djokic LJ, Milojević S, Janoskov J, Behlilović B, Jeremić N (1974). "Clinical evaluation of a new low dose progestagen-only contraceptive containing cingestol". International Journal of Fertility. 19 (3): 171–175. PMID 4375129.
- ^ Cutting WC, Csáky TZ, Barnes BA (1984). Cutting's Handbook of Pharmacology: The Actions and Uses of Drugs. Appleton-Century-Crofts. p. 439. ISBN 978-0-8385-1418-4.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |